A Straightforward Cytometry-Based Protocol for the Comprehensive Analysis of the Inflammatory Valve Infiltrate in Aortic Stenosis

Aortic stenosis (AS) is a frequent cardiac disease in old individuals, characterized by valvular calcification, fibrosis, and inflammation. Recent studies suggest that AS is an active inflammatory atherosclerotic-like process. Particularly, it has been suggested that several immune cell types, present in the valve infiltrate, contribute to its degeneration and to the progression toward stenosis. Furthermore, the infiltrating T cell subpopulations mainly consist of oligoclonal expansions, probably specific for persistent antigens. Thus, the characterization of the cells implicated in the aortic valve calcification and the analysis of the antigens to which those cells respond to is of utmost importance to develop new therapies alternative to the replacement of the valve itself. However, calcified aortic valves have been only studied so far by histological and immunohistochemical methods, unable to render an in-depth phenotypical and functional cell profiling. Here we present, for the first time, a simple and efficient cytometry-based protocol that allows the identification and quantification of infiltrating inflammatory leukocytes in aortic valve explants. Our cytometry protocol saves time and facilitates the simultaneous analysis of numerous surface and intracellular cell markers and may well be also applied to the study of other cardiac diseases with an inflammatory component.

[1]  B. Merkely,et al.  Cellular Senescence, Aging and Non-Aging Processes in Calcified Aortic Valve Stenosis: From Bench-Side to Bedside , 2022, Cells.

[2]  L. Joosten,et al.  Innate immune cells in the pathophysiology of calcific aortic valve disease: lessons to be learned from atherosclerotic cardiovascular disease? , 2022, Basic Research in Cardiology.

[3]  Dai-Min Zhang,et al.  Pathogenesis and Molecular Immune Mechanism of Calcified Aortic Valve Disease , 2021, Frontiers in Cardiovascular Medicine.

[4]  T. Lüscher,et al.  Calcific aortic valve disease: from molecular and cellular mechanisms to medical therapy. , 2021, European heart journal.

[5]  B. Prendergast,et al.  2021 ESC/EACTS Guidelines for the management of valvular heart disease. , 2021, European heart journal.

[6]  K. Koh,et al.  Inflammatory and metabolic mechanisms underlying the calcific aortic valve disease. , 2018, Atherosclerosis.

[7]  Fei Li,et al.  The shift of macrophages toward M1 phenotype promotes aortic valvular calcification , 2017, The Journal of thoracic and cardiovascular surgery.

[8]  P. Libby,et al.  Interferon-γ Released by Activated CD8+ T Lymphocytes Impairs the Calcium Resorption Potential of Osteoclasts in Calcified Human Aortic Valves. , 2017, The American journal of pathology.

[9]  M. Vitale,et al.  Understanding the structural features of symptomatic calcific aortic valve stenosis: A broad-spectrum clinico-pathologic study in 236 consecutive surgical cases. , 2017, International journal of cardiology.

[10]  Seung Hyun Lee,et al.  Involvement of Immune Cell Network in Aortic Valve Stenosis: Communication between Valvular Interstitial Cells and Immune Cells , 2016, Immune network.

[11]  H. Nagaraja,et al.  The aortic stenosis complex: aortic valve, atherosclerosis, aortopathy. , 2015, Journal of cardiology.

[12]  K. Furukawa Recent advances in research on human aortic valve calcification. , 2014, Journal of pharmacological sciences.

[13]  M. Chu,et al.  Bicuspid aortic valve disease , 2013, Canadian Medical Association Journal.

[14]  J. Borer,et al.  Etiology of Valvular Heart Disease in the 21st Century , 2013, Cardiology.

[15]  Kathleen F. Kerr,et al.  Genetic associations with valvular calcification and aortic stenosis. , 2013, The New England journal of medicine.

[16]  L. Lopez,et al.  Moderate Aortic Enlargement and Bicuspid Aortic Valve Are Associated With Aortic Dissection in Turner Syndrome: Report of the International Turner Syndrome Aortic Dissection Registry , 2012, Circulation.

[17]  Jennifer Taylor,et al.  ESC/EACTS Guidelines on the management of valvular heart disease. , 2012, European heart journal.

[18]  I. Šteiner,et al.  Calcific aortic valve stenosis: Immunohistochemical analysis of inflammatory infiltrate. , 2012, Pathology, research and practice.

[19]  K. J. Grande-Allen,et al.  Calcific Aortic Valve Disease : Not Simply a Degenerative Process A Review and Agenda for Research from the National Heart and Lung and Blood Institute Aortic Stenosis Working Group , 2012 .

[20]  R. Winchester,et al.  Circulating Activated and Effector Memory T Cells Are Associated with Calcification and Clonal Expansions in Bicuspid and Tricuspid Valves of Calcific Aortic Stenosis , 2011, The Journal of Immunology.

[21]  I. Šteiner,et al.  Blood vessels and lymphatics in calcific aortic stenosis--in support of its inflammatory pathogenesis. , 2010, Ceskoslovenska patologie.

[22]  B. Popescu,et al.  Calcific aortic valve disease and aortic atherosclerosis--two faces of the same disease? , 2009, Romanian journal of internal medicine = Revue roumaine de medecine interne.

[23]  C. Otto,et al.  Calcific aortic stenosis--time to look more closely at the valve. , 2008, The New England journal of medicine.

[24]  R. Winchester,et al.  The Lymphocytic Infiltration in Calcific Aortic Stenosis Predominantly Consists of Clonally Expanded T Cells1 , 2007, The Journal of Immunology.

[25]  Y. Adler,et al.  Nonobstructive aortic valve calcium as a window to atherosclerosis of the aorta. , 2000, The American journal of cardiology.

[26]  C M Otto,et al.  Prospective study of asymptomatic valvular aortic stenosis. Clinical, echocardiographic, and exercise predictors of outcome. , 1997, Circulation.

[27]  Catherine M. Otto,et al.  Clinical Factors Associated With Calcific Aortic Valve Disease , 1997 .

[28]  Bonnie K. Lind,et al.  Clinical factors associated with calcific aortic valve disease. Cardiovascular Health Study. , 1997, Journal of the American College of Cardiology.